Search

Author/Creator Klippel, Z.

1. 1609 Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170). (September 2015)

Authors:
Pinter, T.; Morrow, P.K.; Cesas, A.; Croitoru, A.; Decaestecker, J.; Gibbs, P.; Hotko, Y.; Jassem, J.; Kurteva, G.; Novotny, J.; O'Reilly, S.; Salek, T.; Khosrowshahi, L.; Reiner, M.; Klippel, Z.; Blanke, C.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S241
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search